Life & Brain
Private Company
Funding information not available
Overview
Life & Brain is a private, revenue-generating service and product company in the genetics and genomics sector. Its core business model revolves around providing comprehensive omics analysis services (e.g., NGS, methylation profiling, proteomics) and developing specialized iPSC-derived cellular models, particularly for neurological and neuroimmunological applications like its LB:MiG microglia. The company leverages its unique academic proximity in Bonn to drive R&D, holds several technology provider certifications, and participates in European research consortia, positioning it as a specialized partner for both academic and industrial clients in the life sciences.
Technology Platform
Integrated omics analysis services (genomics, epigenomics, proteomics) combined with a proprietary iPSC platform for generating specialized cellular models, particularly for the central nervous system. Features AI-based phenotypic analysis (PhenoMiG) for microglia and holds certified provider status for multiple leading technologies (Twist, Olink, Seer).
Opportunities
Risk Factors
Competitive Landscape
Life & Brain competes with large, global contract research organizations (CROs) offering omics services and with other specialized iPSC cell providers. Its differentiation lies in its deep academic integration in neuroscience, its combined omics+cellomics offering, and its focus on complex, AI-enhanced phenotypic assays for niche applications like microglia biology.